Vertex Pharmaceuticals (VRTX) Net Income Attributable to Noncontrolling Interests (2011 - 2018)
Vertex Pharmaceuticals (VRTX) posted Net Income Attributable to Noncontrolling Interests of -$25.43 million for Q4 2018, compared with $1.5 million a year earlier.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Net Income Attributable to Noncontrolling Interests (2011 - 2018) Analysis & Trends
For FY2018, Vertex Pharmaceuticals' Net Income Attributable to Noncontrolling Interests came in at -$9.79 million.
- In prior years, Vertex Pharmaceuticals' Net Income Attributable to Noncontrolling Interests was -$171.85 million in FY2017, $28.02 million in FY2016 and -$31.85 million in FY2015.
- The Q4 2018 figure stands as the lowest quarterly Net Income Attributable to Noncontrolling Interests since Q3 2017.
- According to Business Quant data, Net Income Attributable to Noncontrolling Interests for the three prior quarters was -$290,000 (Q3 2018), -$1.11 million (Q2 2018) and $17.04 million (Q1 2018).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCI Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,224.11 Bn | 1,197.72 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 665.34 Bn | 585.20 Bn | 17.30 Bn | - |
| 3 | AbbVie | 515.72 Bn | 483.73 Bn | 13.12 Bn | 2.00 Mn |
| 4 | Merck | 362.64 Bn | 325.58 Bn | 13.19 Bn | 2.00 Mn |
| 5 | Novartis Ag | 315.51 Bn | 288.75 Bn | - | - |
| 6 | Astrazeneca | 289.26 Bn | 263.15 Bn | 13.26 Bn | -1.00 Mn |
| 7 | Amgen | 249.20 Bn | 200.85 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 207.48 Bn | 182.59 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.49 Bn | 114.85 Bn | 12.56 Bn | 10.00 Mn |
| 10 | Vertex Pharmaceuticals | 138.73 Bn | 110.72 Bn | 2.91 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | -25.43 Mn |
| Sep 30, 2018 | -290,000.00 |
| Jun 30, 2018 | -1.11 Mn |
| Mar 31, 2018 | 17.04 Mn |
| Dec 31, 2017 | 1.50 Mn |
| Sep 30, 2017 | -188.32 Mn |
| Jun 30, 2017 | 13.17 Mn |
| Mar 31, 2017 | 1.79 Mn |
| Dec 31, 2016 | -5.19 Mn |
| Sep 30, 2016 | -696,000.00 |
| Jun 30, 2016 | 28.37 Mn |
| Mar 31, 2016 | 5.53 Mn |
| Dec 31, 2015 | -938,000.00 |
| Sep 30, 2015 | 1.33 Mn |
| Jun 30, 2015 | -32.14 Mn |
| Mar 31, 2015 | -98,000.00 |
| Dec 31, 2013 | -228.83 Mn |
| Sep 30, 2013 | -4.53 Mn |
| Jun 30, 2013 | -4.55 Mn |
| Mar 31, 2013 | -4.61 Mn |
API Access
Vertex Pharmaceuticals Net Income Attributable to Noncontrolling Interests API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-from-non-controlling-interests", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();